Characterization of genotype II Rubella virus strains

Archives of Virology

Volumn 148, Issue 9, 2003, Pages 1835-1850

  Zheng, D P ^a,c   Zhou, Y M ^a   Zhao, K ^b   Han, Y R ^b   Frey, Teryl K ^a  

^a GEORGIA STATE UNIVERSITY   (United States)

^b NATIONAL VACCINE AND SERUM INSTITUTE   (China)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3' UNTRANSLATED REGIONS; 5' UNTRANSLATED REGIONS; GENOTYPE; NUCLEIC ACID CONFORMATION; OPEN READING FRAMES; PHYLOGENY; RUBELLA VIRUS; VIRUS REPLICATION;

RUBELLA VIRUS;

EID: 0141786596     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-003-0132-7     Document Type: Article

References (29)

1. Best JM (1991) Rubella vaccines: past, present and future. Epidemiol Infect 107: 17-30
2. Chantler JK, Lund KD, Miki NP, Berkowitz CA, Tai G (1993) Characterization of rubella virus strain differences associated with attenuation. Intervirology 36: 225-236
3. Chen MH, Frey TK (1999) Mutagenic analysis of the 3′ cis-acting elements of the rubella virus genome. J Virol 73: 3386-3403
4. Clarke DM, Loo TW, Hui I, Chong P, Gillam S (1987) Nucleotide sequence and in vitro expression of rubella virus 24S subgenomic messenger RNA encoding the structural proteins E1, E2, and C. Nucleic Acids Res 15: 3041-3057
5. Dominguez G, Wang CY, Frey TK (1990) Sequence of the genome RNA of rubella virus: Evidence for genetic rearrangement during Togavirus evolution. Virology 177: 225-238
6. Fogel A, Gerichter CB, Barnea B, Handsher R, Heeger E (1978) Response to experimental challenge in persons immunized with different rubella vaccines. J Pediatr 92: 26-29
7. Frey TK (1994) Molecular biology of rubella virus. Adv Virus Res 44: 69-160
8. Frey TK, Abernathy ES, Bosma TJ, Starkey WG, Corbett KM, Best JM, Katow S, Weaver SC (1998) Molecular analysis of rubella virus epidemiology across three continents, North America, Europe, and Asia, 1961-1977. J Infect Dis 178: 642-650
9. Green KY, Dorsett PH (1986) Rubella virus antigens: localization of epitopes involved in hemagglutination and neutralization by using monoclonal antibodies. J Virol 57: 893-898
10. Han YR, Zhao K, Gong YX, Hao SL, Wang SZ, Wang CT (1985) Rubella vaccine in the People's Republic of China. Rev Infect Dis Suppl 1: S79
11. Johansson B, Tecle T, Orvell C (2002) Proposed criteria for classification of new genotypes of mumps virus. Scand J Infect Dis 34: 355-357
12. Kakizawa J, Nitta Y, Yamashita O, Ushijima H, Katow S (2001) Mutations of rubella virus vaccine To-336 strain occurred in the attenuation process of wild progenitor virus. Vaccine 19: 2793-2802
13. Katow S, Minahara H, Fukushima M, Yamaguchi Y (1997) Molecular epidemiology of rubella by nucleotide sequences of the rubella virus E1 gene in three East Asia countries. J Infect Dis 176: 602-616
14. Kew OM, Mulders MN, Lipskaya GY, da Silva EE, Pallansch MA (1995) Molecular epidemiology of polioviruses. Semi Virology 6: 401-414
15. Lund KD, Chantler JK (2000) Mapping of genetic determinants of rubella virus associated with growth in joint tissue. J Virol 74: 796-804
16. Ohtawara M, Kobune F, Umino Y, Sugiura A (1985) Inability of Japanese rubella vaccines to induce antibody response in rabbits is due to growth restriction at 39 degrees. Arch Virol 83: 217-227
17. Parkman PD, Buescher EL, Artenstein MS (1962) Recovery of rubella virus from army recruits. Proc Soc Exp Biol Med 111: 225-230
18. Pougatcheva SO, Abernathy ES, Vzorov AN, Compans RW, Frey TK (1999) Development of a rubella virus DNA vaccine. Vaccine 17: 2104-2112
19. Pugachev KV, Abernathy ES, Frey TK (1997) Genomic sequence of the RA27/3 vaccine strain of rubella virus. Arch Virol 142: 1165-1180
20. Pugachev KV, Frey TK (1998) Effects of defined mutations in the 5′ nontranslated region of rubella virus genomic RNA on virus viability and macromolecule synthesis. J Virol 72: 641-650
21. Singh NK, Atreya CD, Nakhasi HL (1994) Identification of calreticulin as a rubella virus RNA binding protein. Proc Natl Acad Sci (USA) 91: 12770-12774
22. Tzeng WP, Frey TK (2002) Mapping the rubella virus subgenomic promoter. J Virol 76: 3189-3201
23. Wang SS, Han YR, Su WN, Chen J, Zhao K (1984) Studies on the reactogenicity and immunogenicity of the BRD-2 and RA27/3 live attenuated rubella vaccines. Vaccine 2: 277-280
24. Webster WS (1998) Teratogen Update: Congenital rubella. Teratology 58: 13-23
25. Weller TH, Neva FA (1962) Propagation in tissue culture of cytopathic agents from patients with rubella-like illness. Proc Soc Exp Bio Med 111: 215-225
26. Wolinsky JS, McCarthy M, Allen-Cannady O, Moore WT, Jin R, Cao S-N, Lovett A, Simmons D (1991) Monoclonal antibody-defined epitope map of expressed rubella virus protein domains. J Virol 65: 3986-3994
27. Yates PJ, Afzal MA, Minor PD (1996) Antigenic and genetic variation of the HN protein of mumps virus strains. J Gen Virol 77: 2491-2497
28. Zhao K, Han YR, Hao SL, Gong YX, Wang SZ, Wang CT, Li J, Hou XJ, Wang SS (1984) Observation on the attenuation of rubella virus strain BRDII. Chinese J Microbiol and Immunol 4: 161-164
29. Zheng D-P, Zhu H, Revello MG, Gerna G, Frey TK (2003) Phylogenetic analysis of rubella virus isolated during a period of epidemic Transmission in Italy, 1991-1997. J Infect Dis 187: 1587-1597